European Journal of Cancer
Official Journal of EORTC, ECCO, EACR and EUSOMA
Editor-in-Chief: Alexander M. M. Eggermont
See
editorial board for all editorial
board information.
The
European Journal of Cancer (including EJC Supplements), is an international comprehensive oncology
journal that publishes original research, editorial comments, review articles, and news on basic and preclinical research, clinical oncology
(medical, pediatric, radiation, surgical), and on cancer epidemiology and prevention.
Official Journal of the European Organisation
for Research and Treatment of Cancer (EORTC), the European CanCer Organisation (ECCO), the European Association for Cancer Research (EACR),
and the European Society of Breast Cancer Specialists (EUSOMA).
Supplements to the
European Journal of Cancer are published
under the title
EJC Supplements (ISSN 1359-6349). All subscribers to
European Journal of Cancer automatically receive
this publication.
Oral Oncology
A Journal Related to Head and Neck Oncology and Pathology
Oral Oncology now accepts
online-only submissions.
Editor: Ezra Cohen
See
editorial
board for all editorial board information.
Official journal of the European Association of Oral Medicine, International
Association of Oral Pathologists, and the International Academy of Oral Oncology.
Oral Oncology is an international interdisciplinary
journal which draws together for the first time issues relating to the aetiopathogenesis, epidemiology, prevention and management of
oral and perioral tumours and of oral disease in patients with malignancies. Papers are invited on the following aspects of cancers arising
in the lip, tongue, mouth, salivary glands, pharynx, and the related bones, soft tissues, and lymph glands. (1) Natural history of oral
cancer and pre cancer, basic pathology, mestastatic mechanisms. (2) Cellular and molecular markers for diagnosis and prognosis, oncogenes,
viruses, growth factors, and adhesion molecules. (3) Epidemiology, risk factors, prevention, screening, and intervention. (4) Advances
in imaging and other functional diagnostic modalities. (5) Surgical advances, lasers, photo dynamic therapy, cyro surgery, micro vascular
surgery. (6) Multimodality treatment, radiotherapy, chemotherapy, immunotherapy, gene therapy. (7) Advances in reconstruction and rehabilitation,
grafts, alloplasty, bone and connective tissue biology, osteoradionecrosis. (8) Teamwork in cancer care, quality of life, nursing, speech
and swallowing therapy, nutrition, counselling, pain control, terminal care. (9) Oral effects of tumours at both local and distant sites
and their treatment.
Research data may be submitted as a paper, short communication or letter. The journal will consider negative
results from well designed studies, which may be published as short communications or letters. Letters may be published as short communications.
Letters that comment on an article previously published in the same journal or that express a viewpoint about oncology are also invited.
All published papers and short communications, and selected letters containing research data are peer reviewed.
